Gastroenterology

Obesity Medicine

Questions discussed in this category

When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?

Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?

1 Answer available

Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?

2 Answers available

Should GLP-1 agonists be held during chemotherapy?

3 Answers available

Do you routinely check vitamin K levels in post-bariatric surgery patients?

There seems to be little guidance on vitamin replacement in these patients. Vitamin K level < 50 yet PT/INR is normal. Is the vitamin K assay usefu...

1 Answer available

Is there a role for use of GLP1 R agonist or dual agonist therapy for management of post bariatric hypoglycemia and dumping syndrome?

1 Answer available

How do you counsel patients on semaglutide or tirzepatide in light of potential cancer risks?

Do you avoid using these agents only in patients with history of medullary thyroid cancer or pancreatic cancer? Are there other cancer risks we should...

1 Answer available

How do you counsel patients on the use of compounded weight loss medications?

3 Answers available